5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one

C84H85ClF3N33O4 — CID 157096457

IUPAC5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one
SMILESCCCCc1cc(Nc2nncc(-c3ccc4[nH][nH]c(=O)c4c3)n2)n[nH]1.CN(C)CCNc1nnc(Nc2n[nH]c3ccccc23)cc1-c1ccc2[nH][nH]c(=O)c2c1Cl.O=c1[nH][nH]c2ccc(-c3cc(Nc4n[nH]c5ccccc45)nnc3NCCN3CCCCC3)c(C(F)(F)F)c12.O=c1[nH][nH]c2ccc(-c3cnnc(Nc4cc(C5CCCC5)[nH]n4)c3)cc12
InChIInChI=1S/C26H26F3N9O.C22H22ClN9O.C19H19N7O.C17H18N8O/c27-26(28,29)22-15(8-9-19-21(22)25(39)37-33-19)17-14-20(31-24-16-6-2-3-7-18(16)32-36-24)34-35-23(17)30-10-13-38-11-4-1-5-12-38;1-32(2)10-9-24-20-14(12-7-8-16-18(19(12)23)22(33)31-27-16)11-17(28-29-20)25-21-13-5-3-4-6-15(13)26-30-21;27-19-14-7-12(5-6-15(14)22-26-19)13-8-17(24-20-10-13)21-18-9-16(23-25-18)11-3-1-2-4-11;1-2-3-4-11-8-15(23-21-11)20-17-19-14(9-18-25-17)10-5-6-13-12(7-10)16(26)24-22-13/h2-3,6-9,14H,1,4-5,10-13H2,(H,30,35)(H2,33,37,39)(H2,31,32,34,36);3-8,11H,9-10H2,1-2H3,(H,24,29)(H2,27,31,33)(H2,25,26,28,30);5-11H,1-4H2,(H2,22,26,27)(H2,21,23,24,25);5-9H,2-4H2,1H3,(H2,22,24,26)(H2,19,20,21,23,25)
InChIKeyAFGOCBQNAJUMQY-UHFFFAOYSA-N
MW1713.28 g/mol
LogP14.36
Rot. Bonds24

About 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one

5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one (PubChem CID 157096457) has the molecular formula C84H85ClF3N33O4 and a molecular weight of 1713.28 g/mol. Its IUPAC name is 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one.

Molecular Properties

Compound Name5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one
PubChem CID157096457
Molecular FormulaC84H85ClF3N33O4
Molecular Weight1713.28 g/mol
Exact Mass1711.71
IUPAC Name5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one
SMILESCCCCc1cc(Nc2nncc(-c3ccc4[nH][nH]c(=O)c4c3)n2)n[nH]1.CN(C)CCNc1nnc(Nc2n[nH]c3ccccc23)cc1-c1ccc2[nH][nH]c(=O)c2c1Cl.O=c1[nH][nH]c2ccc(-c3cc(Nc4n[nH]c5ccccc45)nnc3NCCN3CCCCC3)c(C(F)(F)F)c12.O=c1[nH][nH]c2ccc(-c3cnnc(Nc4cc(C5CCCC5)[nH]n4)c3)cc12
InChIInChI=1S/C26H26F3N9O.C22H22ClN9O.C19H19N7O.C17H18N8O/c27-26(28,29)22-15(8-9-19-21(22)25(39)37-33-19)17-14-20(31-24-16-6-2-3-7-18(16)32-36-24)34-35-23(17)30-10-13-38-11-4-1-5-12-38;1-32(2)10-9-24-20-14(12-7-8-16-18(19(12)23)22(33)31-27-16)11-17(28-29-20)25-21-13-5-3-4-6-15(13)26-30-21;27-19-14-7-12(5-6-15(14)22-26-19)13-8-17(24-20-10-13)21-18-9-16(23-25-18)11-3-1-2-4-11;1-2-3-4-11-8-15(23-21-11)20-17-19-14(9-18-25-17)10-5-6-13-12(7-10)16(26)24-22-13/h2-3,6-9,14H,1,4-5,10-13H2,(H,30,35)(H2,33,37,39)(H2,31,32,34,36);3-8,11H,9-10H2,1-2H3,(H,24,29)(H2,27,31,33)(H2,25,26,28,30);5-11H,1-4H2,(H2,22,26,27)(H2,21,23,24,25);5-9H,2-4H2,1H3,(H2,22,24,26)(H2,19,20,21,23,25)
InChIKeyAFGOCBQNAJUMQY-UHFFFAOYSA-N
XLogP14.36
TPSA503.99 Ų
H-Bond Donors18
H-Bond Acceptors25
Rotatable Bonds24
Heavy Atoms125
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001713.28
LogP ≤ 514.36
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1025

Analyze 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one?
The IUPAC name of 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one (CID 157096457) is 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one.
What is the SMILES notation for 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one?
The canonical SMILES for 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one is CCCCc1cc(Nc2nncc(-c3ccc4[nH][nH]c(=O)c4c3)n2)n[nH]1.CN(C)CCNc1nnc(Nc2n[nH]c3ccccc23)cc1-c1ccc2[nH][nH]c(=O)c2c1Cl.O=c1[nH][nH]c2ccc(-c3cc(Nc4n[nH]c5ccccc45)nnc3NCCN3CCCCC3)c(C(F)(F)F)c12.O=c1[nH][nH]c2ccc(-c3cnnc(Nc4cc(C5CCCC5)[nH]n4)c3)cc12.
What is the InChIKey of 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one?
The InChIKey is AFGOCBQNAJUMQY-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26F3N9O.C22H22ClN9O.C19H19N7O.C17H18N8O/c27-26(28,29)22-15(8-9-19-21(22)25(39)37-33-19)17-14-20(31-24-16-6-2-3-7-18(16)32-36-24)34-35-23(17)30-10-13-38-11-4-1-5-12-38;1-32(2)10-9-24-20-14(12-7-8-16-18(19(12)23)22(33)31-27-16)11-17(28-29-20)25-21-13-5-3-4-6-15(13)26-30-21;27-19-14-7-12(5-6-15(14)22-26-19)13-8-17(24-20-10-13)21-18-9-16(23-25-18)11-3-1-2-4-11;1-2-3-4-11-8-15(23-21-11)20-17-19-14(9-18-25-17)10-5-6-13-12(7-10)16(26)24-22-13/h2-3,6-9,14H,1,4-5,10-13H2,(H,30,35)(H2,33,37,39)(H2,31,32,34,36);3-8,11H,9-10H2,1-2H3,(H,24,29)(H2,27,31,33)(H2,25,26,28,30);5-11H,1-4H2,(H2,22,26,27)(H2,21,23,24,25);5-9H,2-4H2,1H3,(H2,22,24,26)(H2,19,20,21,23,25).
What are the key properties of 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one?
5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one has a molecular weight of 1713.28 g/mol, XLogP of 14.36, 24 rotatable bonds, 18 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[3-[(5-butyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-5-yl]-1,2-dihydroindazol-3-one;4-chloro-5-[3-[2-(dimethylamino)ethylamino]-6-(1H-indazol-3-ylamino)pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[6-(1H-indazol-3-ylamino)-3-(2-piperidin-1-ylethylamino)pyridazin-4-yl]-4-(trifluoromethyl)-1,2-dihydroindazol-3-one is sourced from PubChem (CID 157096457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).